Skip to main content
OpenTrials
Completed

NCT Number: NCT02089971

Muscle Mass and Function in Chinese Adults

To describe the normal range of muscle mass and function in Chinese adults.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–34 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Peking Union Medical College Hospital, Beijing, China

Loading trial locations.

About this study

The study objective is to setup a normal range of muscle mass and function in Chinese adults.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Young adult ages between 25 and 34 years, inclusively.
  • Adult is judged to be in good health as determined from his/her medical history as his/her self-report to the enrolling center personnel and as confirmed through a clinical examination by a physician.
  • Adult with BMI between 18.5 to 26.9.
  • Male or non-pregnant non-lactating female. Non-pregnant should be confirmed by urine pregnant test. And non-lactating is defined as postpartum more than 18 months.
  • Subject has voluntarily signed and dated an informed consent form, approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) prior to any participation in the study.

Exclusion criteria

  • Subject who is heavy manual labor.
  • Subject who is professional or semi-professional athlete or game player.
  • Subject who is physical disabilities, such as loss of hand or foot or limbs or any physical disability which may affect the physical activities and affect the distribution of muscle mass by the opinion of the study physician.
  • Subject has known chronic diseases such as endocrine system diseases (including type 1 or type 2 diabetes mellitus, or hyperthyroidism or hypothyroidism), cardiovascular diseases, liver diseases, and renal diseases as self-report.
  • Subject who has active infection of TB, HIV and hepatitis as self-report.
  • Subject who currently experiencing diarrhea or anorexia within 7days prior to the enrollment.
  • Subject who has or plans for intensive physical activities 3 days prior to the scheduled BIA measurement.
  • Subject who is thyroid malfunction (as serum fT4 level and/or serum TSH level out of the reference range of the lab)
  • Subject has implanted electronic device, orthopedic metal implantations, such as pacemaker, cardiac defibrillator, or metal hip, metal knee joint, metal fracture internal fixation, etc.
  • Subject is drug addiction or alcohol addiction.
  • Subject is anemia (as blood hemoglobin level less than 120 g/L in males and 110 g/L in females).
  • Subject is malnourished by study physician's opinion
  • Subject has active cancers as self-report
  • Subject has lost or gained more than 5% of body weight in the past 3 months
  • Subject attends other clinical trials and is not approved by AN

Treatment and study plan

Primary outcomes

  1. Total skeletal muscle mass

    Time frame: Test Visit 1 (~ Day 13)

    Dual X-ray Absorptiometry (DXA)

Secondary outcomes

  1. Total body fat

    Time frame: Test Visit 1 (~ Day 13)

  2. Total body fat free mass

    Time frame: Test Visit 1 (~ Day 13)

  3. Total skeletal muscle mass

    Time frame: Test Visit 1 (~ Day 13)

    Bioelectrical Impedance Absorptiometry (BIA)

Sponsors and collaborators

Lead sponsor

Abbott Nutrition

Industry

Registry information

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Mar 18, 2014
Registry last updated
Jan 19, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.